SwePub - search: id:"swepub:oai:research.chalme...

Träfflista för sökning "id:"swepub:oai:research.chalmers.se:76fadecf-d5c5-4356-93e9-910f7c112a3c" "

Search: id:"swepub:oai:research.chalmers.se:76fadecf-d5c5-4356-93e9-910f7c112a3c"

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Leslie, William D, et al. (author) Does osteoporosis therapy invalidate FRAX for fracture prediction? 2012 In: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. - : Wiley. - 1523-4681. ; 27:6, s. 1243-51 Journal article (peer-reviewed)abstract Ten-year fracture risk assessment with the fracture risk assessment system (FRAX) is increasingly used to guide treatment decisions. Osteoporosis pharmacotherapy reduces fracture risk, but the effect is greater than can be explained from the increase in bone mineral density (BMD). Whether this invalidates fracture predictions with FRAX is uncertain. A total of 35,764 women (age ≥50 years) and baseline BMD testing (1996–2007) had FRAX probabilities retroactively calculated. A provincial pharmacy database was used to identify osteoporosis medication use. Women were categorized as untreated, current high adherence users [medication possession ratio (MPR) ≥0.80 in the year after BMD testing], current low adherence users (MPR

Skapa referenser, mejla, bekava och länka

Träfflista för sökning "id:"swepub:oai:research.chalmers.se:76fadecf-d5c5-4356-93e9-910f7c112a3c" "